Adalimumab (a fully human anti-tumour necrosis factor α monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials
Year: 2002
Type: article
Source: Annals of the Rheumatic Diseases
Author: R Rau
Institution: Fachklinik 360°
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2032866406
